FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

FDA Releases More ANDA Draft Bioequivalence Guides

Federal Register notice: FDA makes available additional draft and revised draft product-specific guidances that address bioequivalence study design re...

latest-news-card-1
Medical Devices

Charles River Wants Endotoxin Assay Regulation

Charles River Laboratories petitions FDA to exercise regulatory oversight over both natural and synthetic endotoxin contamination assays.

Medical Devices

Data Don't Support Breakthrough for 510(k)s: Attorney

Attorney and data scientist Bradley Thompson says FDA data support the value of a breakthrough device designation for de novo submissions but not for ...

latest-news-card-1
Medical Devices

FDA Working to Cut Ethylene Oxide Emissions

CDRH director Jeffrey Shuren describes Center efforts to help sterilization facilities to reduce ethylene oxide emissions into the environment.

Medical Devices

Juvderm Volux XC Approved for Jawline Shaping

FDA approves Allergan Aesthetics Juvderm Volux XC for improving jawline definition in adults over the age of 21 with moderate to severe loss of jawlin...

latest-news-card-1
Federal Register

E-submission Guide for Expedited Safety Reports

Federal Register notice: FDA makes available a draft guidance entitled Electronic Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies...

Human Drugs

FDA Approves Cimerli as Generic Lucentis

FDA approves Coherus Cimerli as an interchangeable generic version of Genentechs Lucentis for all five label indications.

FDA General

Looking at the FDA/Industry Revolving Door

A Grid news report uses Linkedin data to estimate how many former FDAers are now working in regulated companies and discusses the ethical issues raise...

latest-news-card-1
Human Drugs

Alnylam Pharmaceuticals Plans NDA for Patisiran

Alnylam Pharmaceuticals plans to file an NDA submission late this year for patisiran, indicated for treating transthyretin-mediated amyloidosis with c...

Federal Register

Panel To Review Amylyx ALS Drug

Federal Register notice: FDA announces a 9/7 Peripheral and Central Nervous System Drugs Advisory Committee meeting that will review Amylyx Pharmaceut...